Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) EBT Margin (2016 - 2025)

Medifast's EBT Margin history spans 16 years, with the latest figure at 8.5% for Q4 2025.

  • For Q4 2025, EBT Margin fell 957.0% year-over-year to 8.5%; the TTM value through Dec 2025 reached 1.46%, down 209.0%, while the annual FY2025 figure was 1.46%, 209.0% down from the prior year.
  • EBT Margin reached 8.5% in Q4 2025 per MED's latest filing, down from 2.97% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 15.56% in Q2 2021 to a low of 8.5% in Q4 2025.
  • Average EBT Margin over 5 years is 7.08%, with a median of 10.19% recorded in 2022.
  • Peak YoY movement for EBT Margin: tumbled -1953bps in 2024, then soared 904bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 12.37% in 2021, then fell by -22bps to 9.61% in 2022, then plummeted by -47bps to 5.13% in 2023, then plummeted by -79bps to 1.07% in 2024, then plummeted by -893bps to 8.5% in 2025.
  • Per Business Quant, the three most recent readings for MED's EBT Margin are 8.5% (Q4 2025), 2.97% (Q3 2025), and 2.72% (Q2 2025).